Skip to Main Content

Paper Details

High tumor burden before blinatumomab has a negative impact on the outcome of adult patients with B-cell precursor acute lymphoblastic leukemia. A real-world study by the GRAALL.
Haematologica
14
2022
Author NameAffiliation
Thomas CluzeauCHU de Nice
Emmanuelle ClappierSaint-Louis Hospital
Herv?? DombretSaint-Louis Hospital, Institut de Recherche Saint-Louis, Universite de Paris
  • 1 - 3

Datasets

Release 1.2